0001656472-21-000029.txt : 20210310 0001656472-21-000029.hdr.sgml : 20210310 20210310173438 ACCESSION NUMBER: 0001656472-21-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210308 FILED AS OF DATE: 20210310 DATE AS OF CHANGE: 20210310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GORENSTEIN MICHAEL RYAN CENTRAL INDEX KEY: 0001797199 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 21731002 MAIL ADDRESS: STREET 1: 111 PETER STREET, SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 4 1 wf-form4_161541565846866.xml FORM 4 X0306 4 2021-03-08 0 0001656472 Cronos Group Inc. CRON 0001797199 GORENSTEIN MICHAEL RYAN 111 PETER STREET, SUITE 300 TORONTO A6 M5V 2H1 ONTARIO, CANADA 1 1 0 0 Executive Chairman COMMON SHARES 2021-03-08 4 M 0 1200000 0.9701 A 9632536 D COMMON SHARES 2021-03-08 4 F 0 410589 9.5354 D 9221947 D COMMON SHARES 2021-03-09 4 S 0 185000 9.9962 D 9036947 D COMMON SHARE OPTION (right to buy) 0.9701 2021-03-08 4 M 0 1200000 0 D 2021-10-06 COMMON SHARES 1200000.0 0 D The price reported was converted from the Canadian exercise price of C$1.23 to U.S. dollars using an exchange rate of C$1.00 to US$0.7887 as reported by Bloomberg as of March 5, 2021. Cronos Group Inc. (the "Company") withheld 410,589 common shares underlying the options for payment of the exercise price and to cover applicable withholding taxes, using the closing price of the Company's common shares on March 5, 2021 of C$12.09 as reported on the Toronto Stock Exchange. The price reported is in U.S. dollars based on the exchange rate of C$1.00 to US$0.7887 as reported by Bloomberg as of March 5, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.90 to $10.07, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4. The options were granted October 6, 2016 and vest in monthly installments over a four-year period. /s/ Eileen Uy, as attorney-in-fact for Michael R. Gorenstein 2021-03-10